Do you want to read an article? Please log in or register.
Inverse association between remnant cholesterol and risks of atrial fibrillation among patients with type 2 diabetes
Atrial Fibrillation
Related content
COMMENTED
Cardiovascular Risk and Diseases
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW
doi: 10.1016/S2213-8587(25)00165-2
Cardiovascular Risk and Diseases
Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies
Ann Intern Med
Saeed A, Mulukutla SR, Thoma F, Lemon L, Koczo A, Reis S, Marroquin O, Kip K
doi: 10.7326/ANNALS-24-00775
Cardiovascular Risk and Diseases
Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study
Diabetes Obes Metab
Ni J, Chen L, Su H, Cai J, Wang C, Lu W, Wang Y, Lu J, Xia T, Zhou J
doi: 10.1111/dom.70214
Atrial FibrillationThrombosis and Stroke
Sex Differences and 2-Year Mortality in Patients With Atrial Fibrillation Diagnosed After Stroke and Known Atrial Fibrillation: A Register-Based Study in Sweden
J Am Heart Assoc
Al Khatib I, Viktorisson A, Abzhandadze T, Sunnerhagen KS
doi: 10.1161/JAHA.124.037608
Atrial FibrillationHeart Failure
Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure
J Am Heart Assoc
Pol T, Lindbäck J, Oldgren J, Alexander JH, Siegbahn A, Wallentin L, Hijazi Z
doi: 10.1161/JAHA.125.045970
Atrial Fibrillation
Impact of steatotic liver diseases on diabetes mellitus risk in patients with atrial fibrillation: a nationwide population study
Cardiovasc Diabetol
Ryu H, Lee SR, Choi EK, Go YH, Lee KY, Choi J, Han S, Kim JH, Ahn HJ, Kwon S, Kim BS, Han KD, Oh S, Lip GYH
doi: 10.1186/s12933-025-02795-5
Myocardial Infarction
Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study
Cardiovasc Diabetol
Tonnesen PT, Olesen KKW, Gyldenkerne C, Hansen MK, Stødkilde-Jørgensen N, Thrane PG, Andersen MH, Poulsen PL, Thomsen RW, Sattar N, Sørensen HT, Maeng M
doi: 10.1186/s12933-026-03085-4
Atrial FibrillationThrombosis and Stroke
Prevalence and Factors Associated With Atrial Fibrillation Among Young Patients With Ischemic Stroke
J Am Heart Assoc
van Kempen EJ, Schellekens MMI, Verhoeven JI, Ekker MS, Verburgt E, Immens MHM, Hilkens NA, Boot EM, van Alebeek ME, Brouwers PJAM, Arntz RM, van Dijk GW, Gons RAR, van Uden IWM, den Heijer T, van Tuijl JH, de Laat KF, van Norden AGW, Vermeer SE, van Zagten MSG, van Oostenbrugge RJ, Wermer MJH, Nederkoorn PJ, van Rooij FG, van den Wijngaard IR, de Leeuw FE, Ten Cate TJF, Tuladhar AM
doi: 10.1161/JAHA.125.043996
Cardiovascular Risk and Diseases
Sex differences in 10-year cardiovascular risk of patients with type 2 diabetes mellitus and subclinical hypothyroidism: a cross-sectional study
Front Endocrinol (Lausanne)
Zhao X, He K, Li J, Zhou L, Liu L, Lu X, Jiang Y
doi: 10.3389/fendo.2025.1635444